This job has expired.
Job Description
Join a Legacy of Innovation 110 Years and Counting!
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology," Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
Summary
The primary responsibilities of this position are to lead studies and projects independently, contribute to due diligence/licensing and strategic decisions, and represent QCP in KOL and regulatory interactions. This position requires advanced understanding of PK-PD and Pop PK-PD, ER/CUI analyses, Phase 1-4 studies, physiological/ pharmacological aspects of the drug, biomarkers, pharmacogenomics, companion diagnostics, and novel approaches to drug development. The person in this position works independently for global projects while establishing KOL and regulatory interactions and interacting with outside vendors as well as regional and global study team members and senior management.
Responsibilities
Subscribe to job alerts and upload your resume!
*By registering with our site, you agree to our
Terms and Privacy Policy.